HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beehive Botanicals consent decree approved

This article was originally published in The Rose Sheet

Executive Summary

The U.S. District Court for the Western District of Wisconsin enters a consent decree of condemnation and injunction against Beehive Botanicals, under which the manufacturer agrees to forfeit certain bee-derived materials to the Department of Justice. The Hayward, Wis., company had product seized this year after FDA found its website made drug claims via links to other sites for its products, including creams and shampoos (1"The Rose Sheet" April 12, 2010). The decree, entered by the court May 14, additionally requires Beehive Botanicals to hire a third-party expert to inspect its labeling and certify the corrections to FDA, according to a DoJ release
Advertisement

Related Content

FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
Advertisement
UsernamePublicRestriction

Register

RS016953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel